{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T06:09:41Z","timestamp":1791180581880,"version":"4.1.0"},"reference-count":27,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,4]]},"DOI":"10.2215\/cjn.01370211","type":"journal-article","created":{"date-parts":[[2011,3,25]],"date-time":"2011-03-25T01:03:05Z","timestamp":1301014985000},"page":"700-703","source":"Crossref","is-referenced-by-count":38,"title":["Sclerostin"],"prefix":"10.2215","volume":"6","author":[{"given":"Tilman B.","family":"Dr\u00fceke","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-H\u00e9l\u00e8ne","family":"Lafage-Proust","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-3-20230811","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1038\/sj.ki.5000414","article-title":"Definition, evaluation, and classification of renal osteodystrophy: A position statement from Kidney Disease: Improving Global Outcomes (KDIGO)","volume":"69","author":"Moe","year":"2006","journal-title":"Kidney Int"},{"key":"R2-3-20230811","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1053\/j.ajkd.2007.08.019","article-title":"Increased risk of hip fracture among men with CKD","volume":"51","author":"Dooley","year":"2008","journal-title":"Am J Kidney Dis"},{"key":"R3-3-20230811","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1038\/sj.ki.5001754","article-title":"Incidence and risk factors for hip or other bone fractures among hemodialysis patients in the Dialysis Outcomes and Practice Patterns Study","volume":"70","author":"Jadoul","year":"2006","journal-title":"Kidney Int"},{"key":"R4-3-20230811","doi-asserted-by":"crossref","first-page":"c256","DOI":"10.1159\/000317207","article-title":"Moderate chronic kidney disease in women is associated with fracture occurrence independently of osteoporosis","volume":"116","author":"Kinsella","year":"2010","journal-title":"Nephron Clin Pract"},{"key":"R5-3-20230811","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1038\/ki.2008.264","article-title":"Chronic kidney disease and bone fracture: A growing concern","volume":"74","author":"Nickolas","year":"2008","journal-title":"Kidney Int"},{"key":"R6-3-20230811","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1111\/j.1525-139X.2009.00650.x","article-title":"A rational guide to reducing fracture risk in dialysis patients","volume":"23","author":"Toussaint","year":"2010","journal-title":"Semin Dial"},{"key":"R8-3-20230811","first-page":"783","article-title":"Evaluation of bone remodeling in hemodialysis patients: Serum biochemistry, circulating cytokines and bone histomorphometry","volume":"22","author":"Ferreira","year":"2009","journal-title":"J Nephrol"},{"key":"R9-3-20230811","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1046\/j.1523-1755.2003.00835.x","article-title":"IL-1beta, TNF-alpha, TGF-beta, and bFGF expression in bone biopsies before and after parathyroidectomy","volume":"63","author":"Santos","year":"2003","journal-title":"Kidney Int"},{"key":"R10-3-20230811","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1097\/01.mnh.0000133975.32559.6b","article-title":"Mechanism of acid-induced bone resorption","volume":"13","author":"Krieger","year":"2004","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"R11-3-20230811","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1038\/ki.2008.60","article-title":"Adynamic bone in patients with chronic kidney disease","volume":"73","author":"Andress","year":"2008","journal-title":"Kidney Int"},{"key":"R12-3-20230811","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1111\/j.1525-139X.2009.00595.x","article-title":"Effects of uremic toxins on vascular and bone remodeling","volume":"22","author":"Barreto","year":"2009","journal-title":"Semin Dial"},{"key":"R13-3-20230811","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1007\/s00774-005-0667-7","article-title":"Uremic toxin and bone metabolism","volume":"24","author":"Iwasaki","year":"2006","journal-title":"J Bone Miner Metab"},{"key":"R14-3-20230811","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1159\/000415733","article-title":"Pathophysiology of aluminum-induced bone disease","volume":"64","author":"Drueke","year":"1988","journal-title":"Contrib Nephrol"},{"key":"R15-3-20230811","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1046\/j.1523-1755.2003.00809.x","article-title":"Dose-dependent effects of strontium on bone of chronic renal failure rats","volume":"63","author":"Schrooten","year":"2003","journal-title":"Kidney Int"},{"key":"R16-3-20230811","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1359\/jbmr.080712","article-title":"Proteins, dietary acid load, and calcium and risk of postmenopausal fractures in the E3N French women prospective study","volume":"23","author":"Dargent-Molina","year":"2008","journal-title":"J Bone Miner Res"},{"key":"R17-3-20230811","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1210\/jcem.84.2.5485","article-title":"Bone mass and dynamic parathyroid function according to bone histology in nondialyzed uremic patients after long-term protein and phosphorus restriction","volume":"84","author":"Lafage-Proust","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"R19-3-20230811","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/s00223-010-9372-1","article-title":"Sclerostin: Current knowledge and future perspectives","volume":"87","author":"Moester","year":"2010","journal-title":"Calcif Tissue Int"},{"key":"R20-3-20230811","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/j.cell.2008.09.059","article-title":"Lrp5 controls bone formation by inhibiting serotonin synthesis in the duodenum","volume":"135","author":"Yadav","year":"2008","journal-title":"Cell"},{"key":"R21-3-20230811","doi-asserted-by":"crossref","first-page":"41614","DOI":"10.1074\/jbc.M110.153890","article-title":"Distinct modes of inhibition by sclerostin on bone morphogenetic protein and Wnt signaling pathways","volume":"285","author":"Krause","year":"2010","journal-title":"J Biol Chem"},{"key":"R22-3-20230811","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.tem.2009.12.002","article-title":"Does osteocytic SOST suppression mediate PTH bone anabolism?","volume":"21","author":"Kramer","year":"2010","journal-title":"Trends Endocrinol Metab"},{"key":"R23-3-20230811","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1002\/jbmr.128","article-title":"Regulation of circulating sclerostin levels by sex steroids in women and in men","volume":"26","author":"Modder","year":"2011","journal-title":"J Bone Miner Res"},{"key":"R24-3-20230811","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1530\/EJE-10-0699","article-title":"Patients with primary hyperparathyroidism have lower circulating sclerostin levels than euparathyroid controls","volume":"163","author":"van Lierop","year":"2010","journal-title":"Eur J Endocrinol"},{"key":"R25-3-20230811","doi-asserted-by":"crossref","first-page":"5056","DOI":"10.1210\/jc.2010-0720","article-title":"Effects of parathyroid hormone treatment on circulating sclerostin levels in postmenopausal women","volume":"95","author":"Drake","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"R26-3-20230811","doi-asserted-by":"crossref","first-page":"1991","DOI":"10.1210\/jc.2009-2283","article-title":"Serum sclerostin levels negatively correlate with parathyroid hormone levels and free estrogen index in postmenopausal women","volume":"95","author":"Mirza","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"R27-3-20230811","doi-asserted-by":"crossref","first-page":"2294","DOI":"10.1093\/ndt\/13.9.2294","article-title":"Bone markers in the diagnosis of low turnover osteodystrophy in haemodialysis patients","volume":"13","author":"Coen","year":"1998","journal-title":"Nephrol Dial Transplant"},{"key":"R28-3-20230811","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1359\/jbmr.081206","article-title":"Sclerostin antibody treatment increases bone formation, bone mass, and bone strength in a rat model of postmenopausal osteoporosis","volume":"24","author":"Li","year":"2009","journal-title":"J Bone Miner Res"},{"key":"R29-3-20230811","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1002\/jbmr.173","article-title":"Single-dose, placebo-controlled, randomized study of AMG 785, a sclerostin monoclonal antibody","volume":"26","author":"Padhi","year":"2011","journal-title":"J Bone Miner Res"}],"container-title":["Clinical Journal of the American Society of Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/01277230-201104000-00003","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T13:40:40Z","timestamp":1786369240000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/01277230-201104000-00003"}},"subtitle":["Just One More Player in Renal Bone Disease?"],"short-title":[],"issued":{"date-parts":[[2011,4]]},"references-count":27,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2011]]}},"URL":"https:\/\/doi.org\/10.2215\/cjn.01370211","relation":{},"ISSN":["1555-9041"],"issn-type":[{"value":"1555-9041","type":"print"}],"subject":[],"published":{"date-parts":[[2011,4]]}}}